54,124 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Edgestream Partners L.P.

Edgestream Partners L.P. purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the second quarter, Holdings Channel reports. The fund purchased 54,124 shares of the pharmacy operator’s stock, valued at approximately $655,000.

A number of other institutional investors also recently added to or reduced their stakes in the company. Marble Harbor Investment Counsel LLC lifted its stake in Walgreens Boots Alliance by 10.4% in the second quarter. Marble Harbor Investment Counsel LLC now owns 495,073 shares of the pharmacy operator’s stock worth $5,988,000 after acquiring an additional 46,525 shares during the last quarter. Plato Investment Management Ltd lifted its stake in Walgreens Boots Alliance by 391,684.6% in the second quarter. Plato Investment Management Ltd now owns 50,932 shares of the pharmacy operator’s stock worth $616,000 after acquiring an additional 50,919 shares during the last quarter. Thompson Siegel & Walmsley LLC lifted its stake in Walgreens Boots Alliance by 98.8% in the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after acquiring an additional 2,992,648 shares during the last quarter. Stoneridge Investment Partners LLC lifted its stake in Walgreens Boots Alliance by 5.1% in the second quarter. Stoneridge Investment Partners LLC now owns 142,643 shares of the pharmacy operator’s stock worth $1,725,000 after acquiring an additional 6,901 shares during the last quarter. Finally, Meeder Advisory Services Inc. acquired a new stake in Walgreens Boots Alliance during the second quarter worth approximately $164,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $8.71 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The stock has a market capitalization of $7.52 billion, a P/E ratio of -1.29, a P/E/G ratio of 1.02 and a beta of 0.70. The company’s fifty day moving average is $10.29 and its two-hundred day moving average is $14.72. Walgreens Boots Alliance, Inc. has a 1 year low of $8.46 and a 1 year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.00 earnings per share. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.48%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on WBA shares. UBS Group cut their price objective on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, July 3rd. JPMorgan Chase & Co. cut their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, September 12th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. Finally, Barclays cut their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a report on Tuesday, July 23rd. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.